Monitoring of Salt Iodisation Programme in Iran; Health Outcomes, Shortages and Perspective Publisher Pubmed



Shamsollahi HR¹ ; Nadarloo M¹ ; Rastkari N² ; Sillanpaa M^{4, 5} ; Yousefi M¹ ; Pasalari H³ ; Nabizadeh R^{1, 2, 6}
Source: Journal of Trace Elements in Medicine and Biology Published:2019

Abstract

Iodine deficiency disorders include a wide range of metabolic and nonmetabolic disorders including goiter. To control IDDs, the World Health Organization and responsible agencies in countries established daily iodine uptake. Almost all the countries in the world provide the required iodine through salt iodisation. IDDs are not completely eradicable, so monitoring the salt iodisation programme is necessary for control of IDDs. In Iran, a salt iodisation programme was started in 1996. In this study, we took salt samples from all legally produced salt brands in Iran in 30 provinces and measured iodine concentration. The results of the monitoring programme for iodine concentration in schoolchildren's urine was used to compare accessibility to iodized salts and health outcomes. The results show that more than 80% of available salts have a suitable or acceptable concentration of iodine. Despite large variance in iodine concentration in available salt in some provinces, the median of iodine concentration in salts is within an acceptable range. Also, the urinary concentration of iodine (national median = 161) confirms that shortage of iodine intake is very low in Iran. The high rate of salt consumption of the Iranian people also has a significant effect on iodine uptake, but can lead to hyperthyroidism and hypertension that must be controlled. © 2018 Elsevier GmbH